Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas Meeting Abstract
| Authors: | Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; Onwasigwe, C.; Ganesan, N.; Pomerantz, L.; Jarjies, C.; Sigler, A.; Geyer, M.; Noy, A.; Straus, D.; Galasso, N.; Inghirami, G.; Horwitz, S.; Weinstock, D.; Hollmann, T.; Dogan, A. |
| Abstract Title: | Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059301193 |
| DOI: | 10.1158/1538-7445.Am2020-4248 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4248 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
